(Q38121605)

29 August 2017

An adipocentric perspective of resveratrol as a calorie restriction mimetic (English)

1 reference

29 August 2017

1 reference

Jamie L Barger

1

1 reference

PubMed ID

23855474

29 August 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

Annals of the New York Academy of Sciences

29 August 2017

1 reference

29 August 2017

1290

1 reference

29 August 2017

122-129

1 reference

Physiological, pathological and potential therapeutic roles of adipokines.

29 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Emerging role of adipose tissue hypoxia in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Inflammation: roles in aging and sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Central obesity and the aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Caloric restriction delays disease onset and mortality in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Attenuation of sarcopenia by dietary restriction in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

The expression of adipogenic genes is decreased in obesity and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

PAGE: parametric analysis of gene set enrichment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Dietary interventions to extend life span and health span based on calorie restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Sirtuin activators mimic caloric restriction and delay ageing in metazoans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Pilot study of resveratrol in older adults with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Adipose tissue microRNAs as regulators of CCL2 production in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Anti-obesity effect of resveratrol-amplified grape skin extracts on 3T3-L1 adipocytes differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Effect of thiazolidinediones on body weight in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

Metabolic reprogramming, caloric restriction and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNYAS.12212

21 January 2018

Identifiers

DOI

10.1111/NYAS.12212

1 reference

29 August 2017

1 reference

PubMed ID

23855474